News | Cath Lab | November 21, 2016

Study Finds STEMI Post-conditioning is Not as Beneficial as Previously Believed

November 21, 2016 – A single-center study sponsored by the National Institutes of Health (NHLBI) failed to show an early benefit of postconditioning (the application of brief periods of ischemia during the initial phase of reperfusion) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention (PCI) and stenting. The study was conducted by researchers at the Minneapolis Heart Institute Foundation after their findings in a previously published small, nonrandomized study demonstrated that patients who underwent postconditioning had improved left ventricular (LV) function following their myocardial infarction.

Principal investigator Jay Traverse, M.D. developed the study to try and improve upon several previous trials from Europe and Asia that found postconditioning had mixed results in the setting of STEMI cases. “We sought to study the most optimal patient population with STEMI that could benefit from postconditioning to see if it is really effective,” Traverse said. “To accomplish that, we only enrolled patients with a totally occluded major coronary artery on presentation without evidence of collateral blood flow, with limited ishemic times between one and six hours and no evidence of pre-infarction angina, a powerful mitigator of infarct size. We also performed the postconditioning intervention immediately upon reperfusion with a guidewire, because the benefits of postconditioning in animals is lost if postconditioning is delayed for even one minute following reperfusion.”

The MRI-based study randomized 165 patients to postconditioning followed by PCI and stenting versus routine primary PCI and stenting. The postconditioning intervention consisted of four 30-second balloon inflations separated by 30 seconds of reperfusion. A total of 101 patients met final enrollment criteria and underwent MRI measurements of infarct size and myocardial salvage one to three days following PCI.

“Unfortunately, we found that the addition of postconditioning to primary PCI had no effect on infarct size and myocardial salvage. In the postconditioning group (n=53), mean infarct size was 21.1 g vs 20.4 g in the control group (n=48) and the myocardial salvage index was 16.8 in the postconditioning group and 15.9 in the control group. No benefit of postconditioning was observed when the data was stratified by ischemic times, sex or age,” Traverse said.
He is not entirely ready to abandon post-conditioning, although it is possible that the reperfusion injury described in animal models may not occur in humans. The research team is analyzing follow-up MRIs from these patients taken at three months and one year. “It is possible that we may see a delayed benefit of postconditioning on LV function since previous studies have not examined this later time point,” he explained.

For more information:

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Overlay Init